✦ LIBER ✦

Treatment of relapsed or refractory Hodgkin disease and non-Hodgkin lymphoma with high-dose chemoradiotherapy followed by unstimulated autologous peripheral stem cell rescue

✍ Scribed by Dr. Aaron P. Rapoport; Jacob M. Rowe; Joanna M. Heal; Martin A. Tanner; John F. Dipersio

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 644 KB
Volume: 40
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830400203

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of refractory and relapsed Hod

Treatment of refractory and relapsed Hodgkin's disease: Intensive chemotherapy and autologous bone marrow or peripheral blood stem cell support

✍ Hurd, David D. ;Haake, Robert J. ;Lasky, Larry C. ;Christiansen, Neal P. ;McGlav 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 719 KB

## Abstract Thirty‐three patients with recurrent or refractory Hodgkin's disease were treated with high‐dose cyclophosphamide, BCNU, and etoposide and supported with either autologous bone marrow or peripheral blood stem cells or both. Peripheral blood stem cells were comparable to bone marrow in s

Mitoxantrone, carboplatin, cytosine arab

Mitoxantrone, carboplatin, cytosine arabinoside, and methylprednisolone followed by autologous peripheral blood stem cell transplantation : A salvage regimen for patients with refractory or recurrent non-Hodgkin lymphoma

✍ Federica Sorá; Nicola Piccirillo; Patrizia Chiusolo; Luca Laurenti; Roberto Marr 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Feasibility and toxicity of high-dose th

Feasibility and toxicity of high-dose therapy (HDT) supported by peripheral blood stem cells in elderly patients with multiple myeloma and non-Hodgkin's lymphoma: Survey from a single institution

✍ Massimo Magagnoli; Luca Castagna; Monica Balzarotti; Barbara Sarina; Inna Timofe 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

High-dose sequential chemotherapy and pe

High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma : A multicenter study of the Intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence

✍ Corrado Tarella; Alessandra Cuttica; Umberto Vitolo; Marina Liberati; Massimo Di 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract ## BACKGROUND The objective of the current study was to evaluate in a multicenter setting the feasibility and efficacy of a high‐dose sequential (HDS) chemotherapy regimen that combined intensive debulking and high‐dose therapy (HDT) with peripheral blood progenitor cell (PBPC) autogra